---
title: "Joseph Baratta to Resign from Blackstone Board, Effective Dec 31, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/302018835.md"
description: "Blackstone director Joseph Baratta will resign from the board effective December 31, 2026, due to planned retirement. Consequently, the board size will decrease from eight to seven members."
datetime: "2026-10-15T20:13:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/302018835.md)
  - [en](https://longbridge.com/en/news/302018835.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/302018835.md)
generator: "portal-rs"
---

# Joseph Baratta to Resign from Blackstone Board, Effective Dec 31, 2026

**Blackstone director Joseph Baratta will resign from the board effective December 31, 2026, as part of his planned retirement.**

Individual

Joseph Baratta

Role

Director

Type of Change

Resignation

Effective Date

December 31, 2026

Reason

Planned retirement

Replacement Info

Board size will be reduced from eight to seven members

Background Details

Will continue to serve as a director until the Effective Date

Board/Committee Role Changes

Not disclosed

Original SEC Filing: Blackstone Inc. \[ BX \] - 8-K - Oct. 15, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [BX.US](https://longbridge.com/en/quote/BX.US.md)

## Related News & Research

- [Goldman Sachs Trims Blackstone Price Target to $125, Maintains Hold on Back-End-Loaded Growth and Valuation Risk](https://longbridge.com/en/news/302979730.md)
- [Blackstone transformed Jersey Mike's. Now it's giving employees a bite of the $7 billion IPO.](https://longbridge.com/en/news/294332024.md)
- [AI fever ignites a boom in thematic ETFs as fund managers hunt for their next big hit](https://longbridge.com/en/news/302963080.md)
- [BeOne Reports 36% Response Rate for BGB-B2033 in Phase 1 Liver Cancer Trial](https://longbridge.com/en/news/302957977.md)
- [BeOne Medicines Ltd. Unveils ESMO Data, Targets HCC Registration in 2026](https://longbridge.com/en/news/302958159.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**